David Hung - 29 Feb 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
4
Filing time
04 Mar 2024, 16:20:13 UTC
Previous filing
09 Jun 2023
Next filing
06 Jun 2024

Key filing fact

David Hung filed Form 4 for Nuvation Bio Inc. (NUVB) on 04 Mar 2024.

Key facts

  • This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 04 Mar 2024, 16:20.

Change

  • Previous filing in this sequence was filed on 09 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

NUVB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+2,000,000
Change %
Price
$0.000000
Shares after
2,000,000
Date
29 Feb 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
2,000,000
Exercise price
$1.87
Footnotes
F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .